LIMK2 and small cell lung carcinoma: In the study, through developing a cisplatin resistance-related ceRNA network, we constructed a SCLC prognostic model based on the expression of two mRNAs, LIM domain kinase 2 (LIMK2) and Phosphatidylinositol 4-kinase IIβ (PI4K2B).